Two European oncology biopharma companies have made the leap onto the stock market: French MaaT Pharma went...
Up To Date
Latest News
European life science investor LSP has raised €850m for its 7th generation flagship fund LSP 7.
Dunad Therapeutics Ltd had entered into a $1.3bn option deal with Swiss pharma major Novartis AG to develop...
Luxembourg-headquartered Covis is taking two COPD drugs off AstraZeneca’s hands in a US$270m deal.
Belgian Agomab Therapeutics NV is expanding its European footprint by acuiring Barcelona-based fibrosis...
German drug discovery company Evotec plans to raise US$576m on the US-American stock exchange Nasdaq to...